Predictors of post-TAVI conduction abnormalities in patients with bicuspid aortic valves.

Giulia Esposito, Niraj Kumar, Francesca Pugliese, Max Sayers, Anthony Wc Chow, Simon Kennon, Mick Ozkor, Anthony Mathur, Andreas Baumbach, Guy Lloyd, Aigerim Mullen, Andrew Cook, Michael Mullen, Kush P Patel

Journal: Open heart 2022;9(2):e001995

PMID: 35790318

Abstract

OBJECTIVES

This study evaluates predictors of conduction abnormalities (CA) following transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valves (BAV).

BACKGROUND

TAVI is associated with CA that commonly necessitate a permanent pacemaker. Predictors of CA are well established among patients with tricuspid aortic valves but not in those with BAV.

METHODS

This is a single-centre, retrospective, observational study of patients with BAV treated with TAVI. Pre-TAVI ECG and CT scans and procedural characteristics were evaluated in 58 patients with BAV. CA were defined as a composite of high-degree atrioventricular block, new left bundle branch block with a QRS >150 ms or PR >240 ms and right bundle branch block with new PR prolongation or change in axis. Predictors of CA were identified using regression analysis and optimum cut-off values determined using area under the receiver operating characteristic curve analysis.

RESULTS

CA occurred in 35% of patients. Bioprosthesis implantation depth, the difference between membranous septum (MS) length and implantation depth (MSID) and device landing zone (DLZ) calcification adjacent to the MS were identified as univariate predictors of CA. The optimum cut-off for MSID was 1.25 mm. Using this cut-off, low MSID and DLZ calcification adjacent to MS predicted CA, adjusted OR 8.79, 95% CI 1.88 to 41.00; p=0.01. Eccentricity of the aortic valve annulus, type of BAV and valve calcium quantity and distribution did not predict CA.

CONCLUSIONS

In BAV patients undergoing TAVI, short MSID and DLZ calcification adjacent to MS are associated with an increased risk of CA.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Address: King's College London Faculty of Life Sciences and Medicine, London, UK.; Cardiology, Barts Health NHS Trust, London, UK.; University College London Institute of Cardiovascular Science, London, UK.; Centre for Advanced Cardiovascular Imaging, Queen Mary University William Harvey Research Institute, London, UK.; Barts Health NHS Trust, London, UK.; Centre for Cardiovascular Medicine and Devices, Queen Mary University William Harvey Research Institute, London, UK.; Barts Heart Centre, Barts Health NHS Trust, London, UK.; Cardiology, Barts Health NHS Trust, London, UK [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.